论文部分内容阅读
本科应用凯时注射液(PGE1)联用大黄虫丸对患慢性肝炎且肝纤维化指标明显异常的患者进行治疗,共观察269例,取得较为满意的疗效。现总结报告如下。1资料与方法1.1一般资料269例慢性肝病患者为2004年1月至2005年9月本科收治的住院患者,均符合2000年西安会议修订的病毒性肝炎诊断
Undergraduate application Kai Shi injection (PGE1) combined with rhubarb worm pills on chronic hepatitis and liver fibrosis indicators were significantly abnormal patients were treated, observed a total of 269 cases, and achieved more satisfactory results. The report is summarized as follows. 1 Materials and Methods 1.1 General Information 269 cases of chronic liver disease patients admitted to hospital from January 2004 to September 2005 were in line with the 2000 meeting in Xi’an, the revised diagnosis of viral hepatitis